Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other biologically active molecules. Its trifluoroacetamido group enhances metabolic stability and influences binding affinity, making it valuable in medicinal chemistry. The stereochemistry at the chiral center allows for selective interactions in biological systems, improving the efficacy and specificity of drug candidates. Commonly employed in asymmetric synthesis and optimization of drug leads where stereocontrol and fluorinated moieties are critical.